Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Biopesticide Firms Take Growth Path
by Marc S. Reisch
March 28, 2011
| A version of this story appeared in
Volume 89, Issue 13
Biopesticide developer AgraQuest has raised $18 million from venture capitalists. The firm, which is planning a stock offering in 2012, says the venture capital will be used for research, technology in-licensing, and acquisitions. Meanwhile, Marrone Bio Innovations, whose CEO, Pam Marrone, founded AgraQuest in 1995, has picked Syngenta to distribute its Regalia biofungicide in Europe, Africa, and the Middle East. Regalia boosts plants’ defenses against fungal and bacterial diseases. AgraQuest recently expanded a supply agreement with Bayer for the garden fungicide Bacillus subtilis strain QST 713 to include France, Italy, and Germany.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter